CAI
Clinical Asset Index
by VOS Supply Group
Drugs · acquisition-cost intelligence

Clindamycin Phosphate 1.2% and Tretinoin 0.025%

clindamycin phosphate and tretinoin· ingredient tretinoinAntibiotics· CLINDAMYCIN PHOSPHATE 10 mg/g; TRETINOIN .25 mg/g; CLINDAMYCIN PHOSPHATE 12 mg/g; TRETINOIN .25 mg/g
What this is. Acquisition-cost intelligence for pharmacy & clinic buyers — the historical trend, generic-equivalent costs, and Part D posture. NADAC is a pharmacy acquisition cost (the national average pharmacies pay), not a retail or cash price — for consumer cash prices use GoodRx/your plan.
Acquisition benchmark · NADAC per GM
$4.30
NADAC — pharmacy acquisition cost, not a retail/cash price

Acquisition-cost history

Weekly NADAC per GM — the trend nobody else shows. 6 weeks.

2025-12-172026-05-20

Same-ingredient options by acquisition cost

Other tretinoin products, cheapest acquisition cost first. Per GM — confirm strength/form equivalence before switching.

ProductNADAC / GMvs this
Retin-A$0.86759−$3.44
tretinoin$0.94183−$3.36
tretinoin$1.26−$3.04
Tretinoin$3.04−$1.27
Atralin$4.23−$0.07690
TRI-LUMA$7.82+$3.52
Tretinoin (Microsphere)$8.71+$4.41
Tretinoin$9.65+$5.35

Medicare Part D coverage · CY2026

On 2 plan formularies · typical tier 2
Prior auth 100% · Step therapy 0% · Quantity limit 50% of formularies

Sources: CMS NADAC (pharmacy acquisition cost), FDA NDC + RxNorm (identity), RxClass (therapeutic class), CMS Medicare Part D formulary (coverage). Observed reference data for professional buyers — not a retail/cash price, not pricing or medical advice. Verify before purchasing or substituting.